Pharmaceuticals firm Mylan will invest up to €76m for five years totaling to €380m to expand its operations in Dublin and Galway and will add more than 500 new positions to its Irish workforce by 2016.
The company, which is Ireland’s largest generics pharmaceutical manufacturer in Ireland, will expand its research and development capabilities and manufacturing abilities within the company’s respiratory, injectables and oral solids franchises in Ireland.
Of the 500 jobs created by 2016, 220 will be based in Galway and the remainder will be in Dublin. Mylan already employs 700 people at its Ireland facilities. It will invest a total of €380m in the expansion.
The funding includes support from the Irish Government through the IDA. Údarás Na Gaeltachta, a regional economic development agency which offers support for Irish-speaking communities, will assist in support the expansion efforts.
“This investment in Mylan’s Irish operations and the growth of our capabilities in the country demonstrate our continued commitment to and confidence in our respiratory franchise and injectables platform, both of which are among Mylan’s many long-term growth drivers,” said Mylan CEO Heather Bresch.
“Ireland also has proven to be a valuable location for Mylan, providing the company with access to a skilled and highly educated workforce that shares our strong work ethic and commitment to excellence.
“I would like to thank Taoiseach (Enda) Kenny, Richard Bruton, Ireland’s Minister for Jobs, Enterprise and Innovation, along with IDA Ireland, for all of their support. Importantly, I’d also like to recognise Mylan’s employees in Ireland for their hard work and dedication to our continued success,” said Bresch.
Life sciences boost
The announcement represents a major boost for the life sciences industry, which employs about 50,000 people in Ireland directly.
“Mylan’s decision to expand in both Dublin and Galway is most welcome news,” said Kenny.
“Mylan is a key member of the Irish pharmaceutical sector and one of the top suppliers in the country, providing the market with high quality generic pharmaceuticals and over-the-counter medicines.
“Today’s announcement, in addition to the company’s proven 25-year track record as a top employer and reliable exporter in Ireland, demonstrates Mylan’s commitment to its Irish operations and recognition for the capabilities of its talented workforce.
“I would like to offer continued support of the Irish Government, and IDA Ireland, to Mylan as it continues to grow in our country and as it further serves as an innovative contributor to the Irish economy,” Kenny said.